Trivascular

Merged

Embrace the evidence

Santa Rosa, United States · Founded 1999 · $267.8M raised

Employees
201–500
Founded
1999
Business Model
B2B
Total Funding
$267.8M
Last Round
$40.0M Series ENov 2013
Rounds
7

About

TriVascular, now part of Endologix, develops endovascular aneurysm repair (EVAR) solutions for abdominal aortic aneurysms. They pioneered technologies for optimal patient outcomes in vascular disease, including the DETOUR System. Focused on disruptive innovation, clinical evidence, and physician training with VR.

Summary

Trivascular is a Biotech company based in Santa Rosa, United States, founded in 1999. It has raised $267.8M in total across 7 rounds, most recently a $40.0M Series E round in Nov 2013. Investors include New Enterprise Associates, MPM Capital and Kaiser Permanente Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ESeries ENov 2013
$40.0M

Sign up to see all 7 rounds

Venture Round through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trivascular on Indexed.vc
<a href="https://indexed.vc/companies/trivascular"><img src="https://indexed.vc/api/badge/company/trivascular" alt="Trivascular on Indexed.vc" width="260" height="76" /></a>